title: Aquaporin-4 knockout abolishes apomorphine-induced tardive dyskinesia following chronic treatment with neuroleptics.
authors.forename: Cun-Jin
authors.initials: CJ
authors.lastname: Su
authors.forename: Xiao-Qing
authors.initials: XQ
authors.lastname: Xu
authors.forename: Yi
authors.initials: Y
authors.lastname: Fan
authors.forename: Ren-Hong
authors.initials: RH
authors.lastname: Du
authors.forename: Gang
authors.initials: G
authors.lastname: Hu
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D014150:Antipsychotic Agents / Q000633:toxicity*; D001058:Apomorphine / Q000494:pharmacology*; D051401:Aquaporin 4 / Q000172:deficiency*; D003024:Clozapine / Q000633:toxicity; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D004195:Disease Models, Animal; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006220:Haloperidol / Q000633:toxicity; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008409:Mastication / Q000187:drug effects / Q000235:genetics; D051379:Mice; D018345:Mice, Knockout; D009043:Motor Activity / Q000187:drug effects; D009069:Movement Disorders / Q000209:etiology* / Q000235:genetics* / Q000473:pathology
chemical_list: D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; C496031:Aqp4 protein, mouse; D051401:Aquaporin 4; D005904:Glial Fibrillary Acidic Protein; D003024:Clozapine; D006220:Haloperidol; D001058:Apomorphine